YOU WONT BELIEVE: 3 - You Need To See This

J&J continues to sell talc-based baby powder in India, despite discontinuing in U.S. and Canada

Company says India is part of global transition to cornstarch-based powder

The Hindu · Aug 28, 2022

3 Stocks to Help You Grow the Nest Egg

The S&P 500 and the Nasdaq closed the last week lower, ending the four-week winning streak on concerns over the hawkish Fed and weak economic data of some of the influential countries. However, investors should consider fundamentally sound growth stocks The Kroger (KR), Johnson & Johnson (JNJ), and Taiwan Semiconductor…

StockNews.com · Aug 22, 2022

Johnson & Johnson baby powder to be removed from all UK stores in 2023

The company cites commercial reasons and has blamed 'misinformation' over the safety of the product for its declining sales in the past.

Daily Record · Aug 13, 2022

5 Durable Stocks to Strengthen Your Portfolio

Given the current market turmoil caused due to surging inflation and the Fed’s aggressive interest rate hikes to bring prices down, it could be wise to invest in stocks that do not fluctuate significantly in adverse market conditions. The solid stability of Johnson & Johnson (JNJ), Coca-Cola FEMSA (KOF), Marubeni…

StockNews.com · Jun 13, 2022

Column: End of Howard Johnson era brings back ice cream memories

An era is over. We have come to the end of the road.

St. Louis Post-Dispatch · Jun 13, 2022

A year on, Quad initiative for 1 billion India-made vaccines runs into rough weather

Production of Johnson & Johnson jab at Hyderabad-based firm’s facility stalled over indemnity and safety issues

The Hindu · May 14, 2022

FDA limits use of Johnson & Johnson COVID vaccine over blood clot risks, agency says

The use of Johnson and Johnson’s COVID-19 vaccine, also known as Janssen, has been limited to “certain individuals” over rare blood clot risks, the U.S. Food and Drug Administration announced Thursday, May 5.

McClatchy Washington Bureau · May 5, 2022

FDA limits Johnson & Johnson's COVID vaccine to some people due to blood clot risk

The chances of dying following after receiving the Janssen vaccine is about 1:2,000,000. But with multiple COVID-19 vaccines available, the FDA is limiting the use of the J&J vaccine.

WEKU · May 5, 2022

New Zealand travel: Everything you need to know as country opens to British tourists from 1 May

After more than two years, tourists can finally return

The Independent UK · Apr 29, 2022

COVID-19 vaccination | Debate on over efficacy of booster doses

Booster or natural infection will reduce the chance of another infection for just a few months, they say.

The Hindu · Mar 27, 2022